TTNP Insider Trading Activity and SEC Form 4 Filings
TTNP insider trading summary
No open-market insider purchases or sales of Titan Pharmaceuticals Inc (TTNP) have been reported on SEC Form 4 in the past 12 months.
Latest TTNP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 21, 2023 | Activist Investing LLC | Insider | Sell | $4.2M (3,388,902 @ $1.23) |
| Jun 21, 2023 | David E. Lazar | Chief Executive Officer | Sell | $442K (359,066 @ $1.23) |
| Jun 21, 2023 | Activist Investing LLC | Insider | Sell | $442K (359,066 @ $1.23) |
| Jun 21, 2023 | David E. Lazar | Chief Executive Officer | Sell | $4.2M (3,388,902 @ $1.23) |
| Jan 25, 2023 | David E. Lazar | Chief Executive Officer | Buy | $20K (20,000 @ $1.00) |
| Jan 25, 2023 | Activist Investing LLC | Insider | Buy | $20K (20,000 @ $1.00) |
| Jan 24, 2023 | David E. Lazar | Chief Executive Officer | Buy | $36K (37,500 @ $0.97) |
| Jan 24, 2023 | Activist Investing LLC | Insider | Buy | $36K (37,500 @ $0.97) |
| Jul 7, 2022 | David E. Lazar | 10% Owner | Buy | $739K (744,294 @ $0.99) |
| Jul 7, 2022 | Activist Investing LLC | Insider | Buy | $739K (744,294 @ $0.99) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.